CMP (Comprehensive Metabolic Panel): Normal vs. Functional Optimal Ranges

What a CMP Actually Measures

A comprehensive metabolic panel is a single blood draw that returns 14 analytes grouped into four categories: glucose metabolism, kidney function, liver health, and electrolyte/protein balance. It is one of the most frequently ordered laboratory tests in the United States, with over 200 million panels run annually in clinical settings.

The test requires an 8 to 12 hour fast for accurate glucose readings. Your lab will report each result against a "reference range," which the Clinical and Laboratory Standards Institute (CLSI) defines as the central 95% interval derived from a supposedly healthy reference population 1. The problem is straightforward: that reference population often includes individuals with undiagnosed insulin resistance, early-stage fatty liver, or subclinical kidney decline. A result sitting at the 97th percentile of a sick population is not the same as optimal. The American Association of Clinical Endocrinology (AACE) has acknowledged this gap directly. In their 2022 clinical practice guidelines, they noted that "prediabetes thresholds based on population distributions may underestimate cardiovascular risk in individuals with fasting glucose values in the high-normal range" 2. Functional medicine practitioners narrow these ranges to identify early metabolic drift before a patient crosses into a diagnostic category.

The Difference Between "Normal" and Functional Optimal

Standard reference ranges tell you whether your result falls outside the statistical norm for the population the lab tested. They are designed to flag disease, not to identify health. A fasting glucose of 98 mg/dL is "normal." It is also one point below the American Diabetes Association's prediabetes cutoff of 100 mg/dL 3.

Functional optimal ranges use a different logic. They draw from epidemiological data linking specific biomarker intervals to the lowest rates of cardiovascular events, all-cause mortality, and organ-specific disease. Dr. Mark Houston, associate clinical professor at Vanderbilt University School of Medicine, has described functional ranges as "the zone where physiology performs best, not merely the zone where pathology has not yet declared itself." These tighter windows give clinicians an earlier signal. Consider this analogy: the standard range is a smoke alarm that goes off when the house is already burning. The functional range is the detector that catches the wiring getting hot.

A 2019 analysis published in The BMJ examined fasting glucose trajectories in over 500,000 Korean adults and found that individuals with fasting glucose between 90 and 99 mg/dL had a 49% higher risk of developing type 2 diabetes over 10 years compared to those between 70 and 85 mg/dL 4. Both groups were "normal." Only one was optimal.

Glucose: The Anchor Marker

Glucose is the first number most patients check. Here is the breakdown.

| Marker | Standard Range | Functional Optimal | |---|---|---| | Fasting glucose | 65-99 mg/dL | 75-86 mg/dL |

The ADA defines prediabetes as fasting glucose of 100-125 mg/dL 3. But risk does not begin at 100. The aforementioned BMJ cohort study showed that each 1 mg/dL increase above 85 mg/dL correlated with a measurable uptick in diabetes incidence 4. A glucose of 92 mg/dL on three consecutive draws should prompt a conversation about insulin resistance, not a reassuring "everything looks fine."

Values below 75 mg/dL in a fasting state may indicate reactive hypoglycemia, adrenal insufficiency, or excess exogenous insulin. The goal is the middle of the functional band, not the lowest possible number. Context matters: athletes with high glycogen turnover may sit at 68-74 mg/dL without pathology, while a sedentary patient at 72 mg/dL warrants a cortisol check.

Kidney Markers: BUN, Creatinine, eGFR, and BUN/Creatinine Ratio

Four CMP analytes assess kidney function. Each tells a slightly different story.

| Marker | Standard Range | Functional Optimal | |---|---|---| | BUN | 6-24 mg/dL | 10-16 mg/dL | | Creatinine | 0.6-1.2 mg/dL (men), 0.5-1.1 mg/dL (women) | 0.8-1.1 mg/dL (men), 0.6-0.9 mg/dL (women) | | eGFR | >60 mL/min/1.73m² | >90 mL/min/1.73m² | | BUN/Creatinine ratio | 10:1-20:1 | 10:1-16:1 |

BUN (blood urea nitrogen) reflects protein metabolism and kidney clearance. Values below 10 mg/dL can signal low protein intake or impaired liver urea synthesis. Values above 16 mg/dL with a normal creatinine may point to dehydration, high protein intake, or GI bleeding rather than kidney disease 5.

The KDIGO 2024 guidelines classify CKD Stage 1 as eGFR >90 with evidence of kidney damage, and Stage 2 as eGFR 60-89 6. Most standard lab reports only flag eGFR below 60. That means a patient at 72 mL/min receives a "normal" result despite already being in Stage 2 CKD. Functional practitioners flag any eGFR below 90 for closer monitoring. An elevated BUN/creatinine ratio above 16:1 with a creatinine in range often indicates dehydration or prerenal azotemia. This is a low-cost, high-signal finding that standard lab flagging misses entirely.

Liver Panel: ALT, AST, Alkaline Phosphatase, and Bilirubin

The CMP includes four markers of hepatobiliary function.

| Marker | Standard Range | Functional Optimal | |---|---|---| | ALT | 7-56 U/L | 10-26 U/L (women), 10-32 U/L (men) | | AST | 10-40 U/L | 10-26 U/L (women), 10-30 U/L (men) | | Alkaline phosphatase (ALP) | 44-147 U/L | 50-100 U/L | | Total bilirubin | 0.1-1.2 mg/dL | 0.2-0.9 mg/dL |

The standard upper limit of ALT has been debated for decades. A 2002 study of 6,835 Italian blood donors with no liver disease found that the true upper limit of normal for ALT was 30 U/L for men and 19 U/L for women 7. The American College of Gastroenterology (ACG) adopted lower thresholds in their 2017 guidelines: 33 U/L for men and 25 U/L for women 8. Many commercial labs still use an upper cutoff of 56 U/L, meaning a patient with an ALT of 48 receives a clean result despite a value that the ACG would flag as abnormal.

This gap carries real clinical weight. A 2021 meta-analysis in Hepatology covering 9.2 million participants found that ALT values in the "high normal" range (above 25 U/L for women and above 33 U/L for men) were associated with a 59% increased risk of non-alcoholic fatty liver disease progression 9. The AST/ALT ratio provides additional signal. An AST/ALT ratio greater than 2:1 suggests alcoholic liver disease, while a ratio below 1:1 is more typical of metabolic-associated steatotic liver disease (MASLD). Bilirubin in the functional range of 0.2-0.9 mg/dL indicates normal heme metabolism. Mildly elevated bilirubin (1.0-2.5 mg/dL) in an otherwise healthy patient often reflects Gilbert syndrome, a benign genetic variant present in 3-7% of the population 10.

Electrolytes: Sodium, Potassium, Chloride, CO2, and Calcium

Five electrolyte markers appear on the CMP. Small shifts carry outsized clinical significance.

| Marker | Standard Range | Functional Optimal | |---|---|---| | Sodium | 136-145 mEq/L | 139-142 mEq/L | | Potassium | 3.5-5.0 mEq/L | 4.0-4.5 mEq/L | | Chloride | 98-106 mEq/L | 100-106 mEq/L | | CO2 (bicarbonate) | 23-29 mEq/L | 25-28 mEq/L | | Calcium | 8.5-10.5 mg/dL | 9.2-10.0 mg/dL |

Sodium deserves particular attention. A 2022 European Heart Journal study of 15,792 participants in the ARIC cohort found that serum sodium above 142 mEq/L at midlife was associated with a 39% increased risk of heart failure and a 21% higher risk of premature mortality over 25 years of follow-up 11. The lead author, Dr. Natalia Dmitrieva of the National Heart, Lung, and Blood Institute, stated: "People whose serum sodium is 142 mEq/L or higher may benefit from evaluation of their hydration status, even though this value falls within what is considered a normal range" 11.

Potassium between 4.0 and 4.5 mEq/L represents the sweet spot. A value of 3.6 mEq/L is technically "normal" but sits at the low end of cardiac safety, especially in patients on diuretics or GLP-1 receptor agonists that alter fluid balance. CO2 below 23 mEq/L may reflect metabolic acidosis from ketosis, renal tubular acidosis, or chronic diarrhea. Above 29 mEq/L, consider metabolic alkalosis secondary to vomiting or diuretic use.

Calcium on the CMP is total calcium, not ionized. A value of 10.3 mg/dL is "normal" but warrants a PTH check to rule out primary hyperparathyroidism, which affects approximately 1 in 500 women over 50 12.

Protein Markers: Albumin and Total Protein

These two markers are often overlooked on a CMP review. They should not be.

| Marker | Standard Range | Functional Optimal | |---|---|---| | Albumin | 3.5-5.5 g/dL | 4.2-5.0 g/dL | | Total protein | 6.0-8.3 g/dL | 6.8-7.8 g/dL |

Albumin is one of the strongest single predictors of all-cause mortality in aging adults. A 2020 analysis in The Lancet covering 243,219 participants found that serum albumin below 4.0 g/dL was independently associated with a 56% increase in all-cause mortality, even after adjusting for age, sex, comorbidities, and inflammatory markers 13. An albumin of 3.6 g/dL is flagged as "normal" on most lab reports. It should prompt a conversation about protein intake, liver synthetic function, chronic inflammation, or malabsorption. Total protein below 6.8 g/dL in a non-pregnant adult may reflect inadequate dietary protein, nephrotic syndrome, or chronic illness depleting globulin fractions.

How to Optimize a Suboptimal CMP

Moving markers from the standard range into functional optimal territory typically involves targeted, measurable interventions rather than broad lifestyle platitudes.

Glucose (if 87-99 mg/dL): The Diabetes Prevention Program (DPP) trial (N=3,234) showed that structured exercise (150 minutes per week) and 7% body weight loss reduced diabetes incidence by 58% in prediabetic adults 14. These interventions are equally applicable to individuals in the "high-normal" glucose range.

BUN (if <10 mg/dL): Low BUN often signals inadequate protein intake. Target 1.2-1.6 g/kg/day of protein, rechecking BUN in 6-8 weeks. If BUN stays low despite adequate protein, assess liver function.

ALT/AST (if above functional cutoffs): Address the most common driver first. MASLD prevalence in the U.S. now exceeds 30% of adults 15. Weight loss of 5-7% body weight has been shown to reduce ALT by 25-30% and to improve hepatic steatosis on imaging 15.

Sodium (if >142 mEq/L): This is a hydration signal first. Increase water intake by 500-1,000 mL/day and recheck in 4 weeks. Persistent elevation above 143 mEq/L with adequate hydration warrants diabetes insipidus screening.

Albumin (if 3.5-4.1 g/dL): Rule out chronic inflammation with a CRP check. If CRP is low, increase dietary protein. If CRP is elevated, address the underlying inflammatory driver before attributing the low albumin to nutrition alone.

Retest Timing and Clinical Decision Points

Not every suboptimal result requires immediate intervention. Timing matters.

Recheck isolated electrolyte abnormalities in 2-4 weeks with attention to hydration status and medication changes. Repeat borderline glucose with a hemoglobin A1c and fasting insulin to assess the full metabolic picture. The ADA recommends A1c testing at minimum every 3 years in adults over 45 with normal results 3.

Liver enzymes in the high-normal functional range should be rechecked in 8-12 weeks after intervention. If ALT or AST remains above the ACG thresholds on two consecutive draws, hepatic ultrasound is the next step 8. Kidney markers trending downward over time (eGFR dropping 3-5 mL/min/year) require nephrology referral regardless of whether the absolute value remains above 60. The KDIGO guidelines explicitly recommend referral for sustained eGFR decline exceeding 5 mL/min/1.73m² per year 6.

A single CMP is a snapshot. Two or three draws over 6-12 months reveal a trajectory, and trajectory is what drives clinical decisions.